🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research study is to test a new type of counseling deve...
Status
Completed
Location
University of Michigan Medical Center
Start Date
2002-04
Trial ID
NCT01517906
Treatments Being Tested
This research project is designed to promote health among first-year colleg...
Status
Completed
Location
University of Minnesota
Start Date
2019-07-31
Trial ID
NCT03930524
Non-specific low back pain (NSLBP) is a prevalent musculoskeletal disorder....
Status
Active Not Recruiting
Location
Rania Reda
Start Date
2026-05-25
Trial ID
NCT07602816
The proposed study aims to evaluate if improving sleep could enhance the in...
Status
Suspended
Location
Queen Mary Hpspital
Start Date
2020-07-01
Trial ID
NCT04457440
Although weight loss programs are effective in the short-term, maintaining ...
Status
Completed
Location
University of South Carolina Department of Exercise Science
Start Date
2008-02
Trial ID
NCT00957008
This randomized, controlled study evaluates the efficacy of weigh loss inte...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2014-07
Trial ID
NCT02466061
The Exercise for COlorectal OLder patients (ECOOL program) is randomized co...
Status
Active Not Recruiting
Location
Hospital general Universitario Gregorio Marañón
Start Date
2022-04-08
Trial ID
NCT05448846
Treatments Being Tested
The Odisha State Malaria Control Program (India) has introduced 'malaria ca...
Status
Completed
Location
Community Welfare Society Hospital
Start Date
2019-08-03
Trial ID
NCT03963869
Treatments Being Tested
The aim of the study is to investigate the effects of two levels of primary...
Status
Completed
Location
Sophiahemmet University
Start Date
2013-11
Trial ID
NCT02374788
Treatments Being Tested
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested